This content is machine translated Cannabis for schizophrenia CBD pre-treatment could exacerbate side effects A significant proportion of people with schizophrenia use cannabis, with around one in five meeting the criteria for a comorbid cannabis use disorder, for which there are still limited effective...…
View Post 4 min This content is machine translated Epilepsy Cannabidiol for refractory epilepsy syndromes The pharmaceutical formulation of high-purity cannabidiol is approved for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex. Despite many years of clinical experience, there...…
View Post 5 min This content is machine translated Medicinal products containing cannabis Miracle cure or marketing hype? Globally, there is a trend toward increased use of preparations containing cannabis. Indications include pain problems or spasticity in the context of neurological diseases. Adverse effects are strongly dose-dependent.
View Post 6 min This content is machine translated Epilepsy Update anticonvulsants What has happened in drug therapy for epilepsy in the last two years? Prof. Hamer from Erlangen provided information about this at the annual meeting of the German and Austrian…
View Post 3 min This content is machine translated Cannabis as a medicine Discrepancy between evidence situation and empirical values In individual cases, significant symptom-relieving efficacy of drugs containing cannabinoids was shown. Individual study results also support positive effects. However, the overall evidence base is not clear at the current…
View Post 8 min This content is machine translated Panacea or fashion trend? Cannabis in the symptomatic treatment of multiple sclerosis. For the past year, patients with multiple sclerosis in Switzerland have been able to be prescribed Sativex®, a spray containing delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), without prior special authorization. THC…
